Literature DB >> 33396412

Rheumatoid Arthritis in the View of Osteoimmunology.

Mélanie Auréal1,2, Irma Machuca-Gayet1, Fabienne Coury1,2.   

Abstract

Rheumatoid arthritis is characterized by synovial inflammation and irreversible bone erosions, both highlighting the immense reciprocal relationship between the immune and bone systems, designed osteoimmunology two decades ago. Osteoclast-mediated resorption at the interface between synovium and bone is responsible for the articular bone erosions. The main triggers of this local bone resorption are autoantibodies directed against citrullinated proteins, as well as pro-inflammatory cytokines and the receptor activator of nuclear factor-κB ligand, that regulate both the formation and activity of the osteoclast, as well as immune cell functions. In addition, local bone loss is due to the suppression of osteoblast-mediated bone formation and repair by inflammatory cytokines. Similarly, inflammation affects systemic bone remodeling in rheumatoid arthritis with the net increase in bone resorption, leading to systemic osteoporosis. This review summarizes the substantial progress that has been made in understanding the pathophysiology of systemic and local bone loss in rheumatoid arthritis.

Entities:  

Keywords:  bone erosion; inflammatory bone loss; osteoclast; rheumatoid arthritis

Mesh:

Substances:

Year:  2020        PMID: 33396412      PMCID: PMC7823493          DOI: 10.3390/biom11010048

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  137 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  Dendritic cell-mediated in vivo bone resorption.

Authors:  Radhashree Maitra; Antonia Follenzi; Arash Yaghoobian; Cristina Montagna; Simone Merlin; Elvira S Cannizzo; John A Hardin; Neil Cobelli; E Richard Stanley; Laura Santambrogio
Journal:  J Immunol       Date:  2010-06-25       Impact factor: 5.422

Review 3.  The serum level of Dickkopf-1 in patients with rheumatoid arthritis: A systematic review and meta-analysis.

Authors:  Yubo Ma; Xu Zhang; Mengmeng Wang; Qing Xia; Jiajia Yang; Meng Wu; Renfang Han; Mengya Chen; Xingxing Hu; Yaping Yuan; Rui Liu; Guangming Jiang; Guixia Pan; Yanfeng Zou; Shengqian Xu; Faming Pan
Journal:  Int Immunopharmacol       Date:  2018-04-14       Impact factor: 4.932

4.  Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register.

Authors:  G Haugeberg; T Uhlig; J A Falch; J I Halse; T K Kvien
Journal:  Arthritis Rheum       Date:  2000-03

5.  Two configurations of static magnetic fields for treating rheumatoid arthritis of the knee: a double-blind clinical trial.

Authors:  N A Segal; Y Toda; J Huston; Y Saeki; M Shimizu; H Fuchs; Y Shimaoka; R Holcomb; M J McLean
Journal:  Arch Phys Med Rehabil       Date:  2001-10       Impact factor: 3.966

6.  The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.

Authors:  Attila Mócsai; Mary Beth Humphrey; Jessica A G Van Ziffle; Yongmei Hu; Andrew Burghardt; Steven C Spusta; Sharmila Majumdar; Lewis L Lanier; Clifford A Lowell; Mary C Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

7.  Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study.

Authors:  Stephanie Finzel; Juergen Rech; Sarah Schmidt; Klaus Engelke; Matthias Englbrecht; Georg Schett
Journal:  Ann Rheum Dis       Date:  2012-05-14       Impact factor: 19.103

8.  Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis.

Authors:  A Croce; O Firuzi; F Altieri; M Eufemi; R Agostino; R Priori; M Bombardieri; C Alessandri; G Valesini; L Saso
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

9.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

10.  Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism.

Authors:  Gustaf Wigerblad; Duygu B Bas; Cátia Fernades-Cerqueira; Akilan Krishnamurthy; Kutty Selva Nandakumar; Katarzyna Rogoz; Jungo Kato; Katalin Sandor; Jie Su; Juan Miguel Jimenez-Andrade; Anja Finn; Alex Bersellini Farinotti; Khaled Amara; Karin Lundberg; Rikard Holmdahl; Per-Johan Jakobsson; Vivianne Malmström; Anca I Catrina; Lars Klareskog; Camilla I Svensson
Journal:  Ann Rheum Dis       Date:  2015-11-27       Impact factor: 19.103

View more
  13 in total

1.  EZH2 regulates the balance between osteoclast and osteoblast differentiation to inhibit arthritis-induced bone destruction.

Authors:  Fang Cheng; Huimin Li; Jing Liu; Fengfeng Yan; Yu Chen; Haiyan Hu
Journal:  Genes Immun       Date:  2022-05-17       Impact factor: 2.676

2.  The effect of flaxseed with or without anti-inflammatory diet in patients with rheumatoid arthritis, a randomized controlled trial.

Authors:  Maryam Ghaseminasab-Parizi; Mohammad-Ali Nazarinia; Masoumeh Akhlaghi
Journal:  Eur J Nutr       Date:  2021-11-27       Impact factor: 5.614

Review 3.  Inflammasomes and the IL-1 Family in Bone Homeostasis and Disease.

Authors:  Hsu-Wen Tseng; Selwin Gabriel Samuel; Kate Schroder; Jean-Pierre Lévesque; Kylie A Alexander
Journal:  Curr Osteoporos Rep       Date:  2022-05-14       Impact factor: 5.163

Review 4.  Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis.

Authors:  Naoki Kondo; Takeshi Kuroda; Daisuke Kobayashi
Journal:  Int J Mol Sci       Date:  2021-10-10       Impact factor: 5.923

Review 5.  Regulation of the mesenchymal stem cell fate by interleukin-17: Implications in osteogenic differentiation.

Authors:  Jelena Krstić; Slavko Mojsilović; Sonja S Mojsilović; Juan F Santibanez
Journal:  World J Stem Cells       Date:  2021-11-26       Impact factor: 5.326

Review 6.  Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells.

Authors:  Hideki Kitaura; Aseel Marahleh; Fumitoshi Ohori; Takahiro Noguchi; Yasuhiko Nara; Adya Pramusita; Ria Kinjo; Jinghan Ma; Kayoko Kanou; Itaru Mizoguchi
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

7.  Effects of the Interleukin-6 Receptor Blocker Sarilumab on Metabolic Activity and Differentiation Capacity of Primary Human Osteoblasts.

Authors:  Annett Klinder; Janine Waletzko-Hellwig; Marie-Luise Sellin; Anika Seyfarth-Sehlke; Markus Wolfien; Franziska Prehn; Rainer Bader; Anika Jonitz-Heincke
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

Review 8.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

9.  Fc Gamma Receptors as Regulators of Bone Destruction in Inflammatory Arthritis.

Authors:  Yuyue Zuo; Guo-Min Deng
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

10.  The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis.

Authors:  David Castro-Vazquez; Amalia Lamana; Paula Arribas-Castaño; Irene Gutiérrez-Cañas; Raúl Villanueva-Romero; Selene Pérez-García; Carmen Martínez; Yasmina Juarranz; Sara Fernández de Córdoba; Isidoro González-Álvaro; Rosa P Gomariz; Mar Carrión
Journal:  Biomedicines       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.